Indeed, it has already been reported that the CD95L-CD95 system contributes to AICD of tumor infiltrating CD8+ T cells in anti-PD1/anti-CTLA-4 treated mice (Zhu et al., 2017), opening the possibility that TNF and CD95L act in this scenario in a redundant fashion. The gene discussed is CD8A; the disease is neoplasm.